期刊文献+

两种选择性环氧化酶-2抑制剂对翼状胬肉成纤维细胞生长影响的对比研究 被引量:2

Investigation of two selective cyclooxygenase-2 inhibitors on HPF
下载PDF
导出
摘要 目的:观察两种选择性环氧化酶-2(COX-2)抑制剂对体外培养人翼状胬肉成纤维细胞(HPF)增殖和凋亡的影响,并比较两者作用强弱,寻找辅助治疗和预防翼状胬肉复发的新途径。方法:用0~200μmol/L尼美舒利(nimesulide)和美洛昔康(meloxicam)作用体外培养的HPF,24~96h后观察不同浓度的两种药物对HPF的影响。MTT法及免疫组织化学染色增生细胞核抗原(PCNA)检测细胞生长活性,流式细胞仪测定细胞周期时相变化。结果:在尼美舒利50μmol/L作用24h后,美洛昔康100μmol/L作用24h后均能显著抑制HPF的增殖(P<0.05),呈剂量和时间依赖性。100μmol/L尼美舒利和美洛昔康分别作用48h后,流式细胞仪检测结果发现,药物作用组均出现典型的亚二倍体凋亡峰,G0/G1期细胞百分比上升(P<0.05),S期细胞百分比下降(P<0.05),说明细胞阻滞于G0/G1期。当尼美舒利的浓度在25~200μmol/L,美洛昔康在50~200μmol/L范围内能浓度依赖性地抑制细胞表达PCNA(P<0.05)。结论:两种选择性COX-2抑制剂均能抑制HPF的生长,并诱导其调亡,对COX-2的选择性越高,对HPF的抑制作用越强,尼美舒利的作用强于美洛昔康。 ·AIM:To investigate the effect of two selective cyclooxy-genase-2(COX-2)inhibitors(nimesulide and meloxicam)on proliferation and apoptosis of human pterygium fibroblasts(HPF)in culture and search for a new method to prevent the recurrence after pterygium surgery.·METHODS:HPF was incubated with 0-200μmol/L nime-sulide and meloxicam for 24-96 hours.The MTT method was used to assay the biologic activities of the two drugs in different time and different doses.The expression of proliferating cell nuclear antigen(PCNA)in each group was detected by immunohistochemistry method.The cell cycle distribution was measured by flow cytometic analysis.·RESULTS:Administration of 50μmol/L nimesulide or 100μmol/L meloxicam for 24 hours significantly inhibited HPF proliferation in a dose-and time-dependent manner(P〈0.05).After treated with the two drugs in 100μmol/L for 48 hours,there was significant sub-G1 peak.The number of HPF in G0/G1 phase increased,but in S phase decreased(P〈0.05),suggesting cells were arrested in G0/G1 phase.The nime-sulide(25-200μmol/L)and meloxicam(50-200μmol/L)inhibited the expression of PCNA in HPF in a dose-depen-dent manner(P〈0.05).·CONCLUSION:Two selective COX-2 inhibitors can significantly inhibit HPF proliferation and induce its apoptosis.The higher selecti on of COX-2 has the stronger inhibition on the growth of HPF.·
出处 《国际眼科杂志》 CAS 2010年第8期1497-1499,共3页 International Eye Science
关键词 翼状胬肉 成纤维细胞 选择性环氧化酶-2抑制剂 尼美舒利 美洛昔康 pterygium human pterygium fibroblasts selective cyclooxygenase-2 inhibitor nimesulide meloxicam
  • 相关文献

参考文献13

  • 1Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989 ;3:218-226.
  • 2Zhang F, Warskulat U, Wettstein M, et al. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem J 1995 ; 312 : 135-143.
  • 3Sellers RS, Silverman L, Khan KN. Cyclooxygenase-2 expression in the cornea of dogs with keratitis. Vet Pathol 2004 ;41 (2) : 116-121.
  • 4Tuo J, Tuaillon N, Shen D, et al. Endotoxin-induced uveitis in cy- clooxygenase-2-deficient mice. Invest Ophthalmol Vis Sci 2004;45 (7) : 2306-2313.
  • 5Marshall JL, Stanfield KM, Silverman L, et al. Enhanced expression of cyclooxygenase-2 in glaucomatous dog eyes. Vet Opbthalmol 2004 ;7 ( 1 ) :59-62.
  • 6孔玮,张劲松,张雪岩,孔珺.环氧合酶-2在bFGF诱导的人晶状体上皮细胞增殖中的表达[J].中国实用眼科杂志,2004,22(12):964-968. 被引量:4
  • 7Ayalasomayajula SP, Kompella UB. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in astreptozotoein-induced diabetic rat model. Eur J Pharmacol 2003 ;458 (3) :283-289.
  • 8Wilkinson-Berka JL, Alousis NS, Kelly DJ, et al . COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sei 2003;44(3):974-979.
  • 9李晓东.第二代COX-2抑制剂[J].世界临床药物,2003,24(11):677-682. 被引量:3
  • 10Husain SS, Szabo IL, Pal R, et al. MAPK (ERK2) kinase-a key targe for NSAIDs- induced inhibition of gastric cancer cell proliferation and growth. Life Sci 2001 ;69:3045.

二级参考文献13

  • 1鲍仕慧,周望者.选择性COX-2抑制剂的心血管安全性评价[J].儿科药学杂志,2005,11(5):6-8. 被引量:4
  • 2Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase- 2 expression in breast cancer [J]. Cancer Res, 2002, 62 (3): 632~635
  • 3Soslow RA, Dannenberg AJ, Rush D, et al. COX - 2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer,2000, 89 (12) :2637~2645
  • 4Yamashita T, Hashimoto S, Kaneko S, et al. Comprehensive gene expression profile of a normal human liver. Biochem Biophys Res Commun, 2000, 269:110~116
  • 5Gospodarowicz D, Mescher AL, Brown KD, et al. The role of fibroblast growth factor and epitdermal growth factor in the proliferative response of the corneal and lens epithelium. Exp Eye Res, 1977, 25(6): 631~649
  • 6Schwegerer L, Ferrara N, Haaparanta T, et al. Basic fribroblast growth factor: expression in cultured cells derived from corneal endothelium and lens epithelium. Exp Eye Res, 1988, 46 (1): 71~80
  • 7I.Michael Wormstone, zkatia Del Rio- Tsonis, et al. FGF: An Autocrine Regulator of Human Lens Cell Growth Independent of Added Stimuli. Invest Ophthalmol Vis Sci, 2001, 42 (6): 1305~1311
  • 8Narniki M, Tagami Y, Yamamoto M, et al. Presence of human epidermal growth factor (hEGF), basic fibroblast growth factor(bFGF) in human aqueous. Nippon Ganka Gakkai Zasshi, 1992,96: 652 ~ 656
  • 9Olivero DK, Furcht LT. Type Ⅳ collagen, Iaminin, and fibronectin promote the adhesion and migration of rabbit lens epithelial cells in vitro. Invest Ophthalmol Vis Sci, 1993, 34 (10): 2825~2834
  • 10张馨,陆付耳.抗炎与免疫调节在糖尿病肾病治疗中的地位[J].中国中西医结合杂志,2010,30(6):649-654. 被引量:24

共引文献42

同被引文献9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部